This patent document pertains generally to an implantable medical device and its connection with one or more electrical leads. More particularly, but not by way of limitation, this patent document pertains to a resealable seal member including a lubricated passage adapted to admit an instrument therethrough and reliably isolate electrical contacts from bodily fluids in the absence of such instrument.
Pacemakers and other implantable medical devices (referred to as “IMDs”), such as cardiac defibrillators, require a means of passing electrical signals between the device and one or more (relatively remote) portions of a patient's body (e.g., the heart). To transmit these electrical signals from the device to the heart, at least one implantable lead is conventionally used. The at least one lead makes electrical contact with the device on a lead terminal portion through a lead terminal pin or a lead terminal ring(s). After a connection between the lead and the device has been established, the electrical signals may be transmitted from the device to the heart (or other remote portion of the patient's body) via the at least one lead. To ensure an uninterrupted electrical path between the device and the heart (or elsewhere), a strong and reliable connection between the implantable lead and the device is desirable.
Another quality of the interconnection between the device and the at least one lead is that such connection should be detachable after being (previously) attached. Under certain circumstances, the device may need to be removed from the patient while the lead remains in place to be used with a new device. Accordingly, a means for securably connecting the lead with the device should also allow the lead to be removed from the device after a length of time (e.g., one or more years) without damage to the lead.
After establishing a tight and secure connection, bodily fluids should be prevented from invading (i.e., leaking into) the vicinity of the connection and contacting associated electrical contacts. Among other things, the leakage of bodily fluids into or near the connection arrangement may cause corrosion of connector parts or short-circuiting of the electrical signals produced or received by the device. For instance, the short-circuiting of the electrical signals may result in a partial loss of stimulation pulses that are intended to be supplied to the heart or non-physiologic noise, the latter of which may be sensed by the device resulting in inappropriate therapy being delivered. Additionally, due to the short-circuiting, tissue in the region of the interconnection may be undesirably stimulated, which may result in muscle spasms that are uncomfortable for the patient.
In the drawings, which are not necessarily drawn to scale, like numerals describe substantially similar components throughout the several views. Like numerals having different letter suffixes represent different instances of substantially similar components. The drawings illustrate generally, by way of example, but not by way of limitation, various embodiments discussed in the present document.
The following detailed description includes references to the accompanying drawings, which form a part of the detailed description. The drawings show, by way of illustration, specific embodiments in which the present members, assemblies, systems, and methods may be practiced. These embodiments, which are also referred to herein as “examples,” are described in enough detail to enable those skilled in the art to practice the present members, assemblies, systems, and methods. The embodiments may be combined, other embodiments may be utilized, or structural or logical changes may be made without departing from the scope of the present members, assemblies, systems, and methods. The following detailed description is, therefore, not to be taken in a limiting sense, and the scope of the present members, assemblies, systems, and methods are defined by the appended claims and their legal equivalents.
In this document the terms “a” or “an” are used to include one or more than one; the term “or” is used to refer to a nonexclusive or unless otherwise indicated; and the term “subject” is used to include the term “patient.” In addition, it is to be understood that the phraseology or terminology employed herein, and not otherwise defined, is for the purpose of description only and not of limitation.
Introduction
Due to the often life sustaining functions provided by IMDs, a failure to maintain a connection between a device and a lead (which transmits device-generated therapy to one or more remote portions of a body into which the device is implanted) could be detrimental. Accordingly, it is important that a lead is safely secured to an IMD to prevent it from being inadvertently decoupled therefrom. In addition, instances may exist where it is desirably to detach the lead from the IMD, and thus such secure connection should also be readily detachable. As one example, the IMD may need to be removed and replaced as a complete unit without disturbing the electrode(s) disposed on the lead. After the lead is safely secured to the IMD, it is important that bodily fluids are not allowed to leak into or near the interconnection; as such leakage can cause a partial diversion of energy that may affect the delivery of life sustaining functions provided by the IMD (due to, e.g., electrical shorting) and may further result in irregular sensing by the lead electrodes.
Advantageously, the present members, assemblies, systems, and methods provide a resealable seal member including a lubricated passage, which provides quick and convenient instrument access to a retaining assembly for securing or releasing a terminal portion of a lead and an IMD. In addition, the present members, assemblies, systems, and methods provide liquid tight sealing of the (device and lead) interconnection in an absence of the instrument.
Examples
Turning now to the drawings,
IMD 102 includes a source of power 250 (
In this example, but as may vary, a bipolar lead is shown. The bipolar lead includes two terminal connectors (i.e., a terminal pin 204 and a terminal ring 206) disposed on lead terminal portion 110 and two electrodes 208 and 210 disposed on lead distal portion 112. Terminal pin 204 and terminal ring 206 are electrically coupled to respective electrodes 208 and 210 via at least two conductors contained within lead body 202. In addition or alternative to electrodes 208 or 210 (which are typically adapted to sense or stimulate heart 108), lead distal portion 112 may also includes means for sensing one or more other physiological parameters, such as pressure, oxygen saturation, or temperature, or for the delivery of one of more drugs. As shown, a drug collar 212 adapted to time release one or more drugs to a subject 106 (
Header portion 256 is formed on or attached to can portion 254. In one example, header portion 256 comprises an epoxy resin, polyurethane, or similar polymer material, which is formed, molded, or assembled with one or more other members of the header (e.g., an electrical terminal(s) 258). In this example, but as may vary, header portion 256 includes a first bore 260, a second bore 262, and a third bore 264. First bore 260 is typically longitudinally disposed inward from a header front surface 266 and is typically sized and shaped to receive an electrically conductive terminal portion 110 of one or more leads, such as a bipolar lead 104, as illustrated in
In this example, second 262 and third 264 bores are typically disposed substantially transverse to first bore 260 and open to both the first bore and an exterior surrounding surface 270 of the header 256. Second 262 and third 264 bores are typically positioned to align with respective terminal connectors (e.g., lead terminal pin 204 (
As shown, first retaining assembly 302 is mounted in second bore 262 and second retaining assembly 304 is mounted in third bore 264. The retaining assemblies 302, 304 releasably engage its associated one of lead terminal pin 204 or lead terminal ring 206, such as for a mechanical mounting of lead 104 to header 256. In varying examples, each retaining assembly 302, 304 includes, at least in part, a receptacle 306 and a fastener 308 configured to engage with receptacle 306. In one example, but as may vary, each receptacle 306 includes one or more internal threads and each fastener 308 includes one or more external threads conforming to the internal threads. In such an example, an instrument 402 (
In the example shown in
Due to the fact that IMD 102 is exposed to bodily fluids, a reliable seal for sealing first 262 and second 264 bores is desired to electrically isolate retaining assemblies 302, 304 and protect the interconnection between lead 104 and IMD 102 from exposure to the bodily fluids. To allow for the actuation (e.g., the rotation) of a portion of the retaining assemblies 302, 304, the seal should allow an instrument to be inserted therethrough as desired by a caregiver. Advantageously, present seal member 500 (see also,
As shown, seal member 500 is typically disposed in second 262 and third 264, such as bores between each bore's respective retaining assembly (i.e., 302, 304) and an exterior surface 270 of header 256. In one example, but as may vary, sealing member 500 includes a circular shape having a diameter at least as large as a diameter of the second 262 or third 264 bores. In such an example, seal member 500 may be compressively secured in one of the bores. In another example, a biocompatible medical adhesive is used to secure seal member 500 in a respective one of the bores 262 or 264.
Seal member 500 helps provide electrical and fluid isolation of retaining assemblies 302, 304 from bodily fluids located proximate to exterior surface 270 of the IMD housing. A lubricated passage 504 therethrough promotes low shear insertion of instrument 402 (
As illustrated in
Non-lubricated seal member 400, like lubricated seal member 500 (e.g., a seal member including a lubricated passage 504 shown in
In
In brief, without the use of one or more lubricants applied to a passage of a seal member, portions of the seal member may rebond to one another. Additionally, the lack of a lubricant may result in a high shear stress present between an inserted instrument and a seal member causing, among other things, wearing of a surface of the seal member or deflection of one or more seal member portions, all of which may jeopardize the sealing ability of the seal member upon removal of the instrument.
The addition of one or more biocompatible or fluorosilicone lubricants 502 to a passage 504 of a seal member 500 increases the reliability of the seal system when breached by an instrument 402 (due to little or no seal member damage). According to one example, but as may vary, the lubricant is applied by inserting a tool (e.g., a rod) coated with lubricant through passage 504 either manually or with an automated system.
As shown in
At 606, the instrument is engaged with a portion of the retaining assembly (e.g., a fastener) contained in the second bore and manipulated (e.g., rotated) to actuate the retaining assembly at 608. In one example, manipulation of the instrument in a first direction effectuates a coupling between the lead and the device housing. A coupling of the lead and device housing secures the lead mechanically within the housing, as well as establishes an electrical connection between electrical circuitry of the IMD and the lead. Should the need arise to adjust the positioning of the lead within the housing or to remove the lead or IMD for inspection or replacement, release of the lead from the IMD may be accomplished by manipulation of the instrument (at 608) in a second direction. At 610, the instrument is removed from the second housing allowing the lubricated passage of the seal member to seal in a liquid tight manner. The instrument may be similarly inserted into another housing bore to actuate the associated retaining assembly disposed therein.
Conclusion
Among other things, a body implantable retaining assembly for forming an electrical and mechanical connection between an implantable medical device and one or more leads is discussed. The retaining assembly is mounted within a housing of the device (e.g., a header portion) and is positioned to align with a lead terminal pin or a lead terminal ring when the lead is inserted into a portion of the device. The retaining assembly is adjustable by an instrument to engage or release the lead and the device. A seal member provides electrical and fluid isolation of the retaining means from bodily fluid located proximate to an exterior surface of the device housing. The seal member includes a lubricated passage therethrough, which is elastically deformable to allow (low shear) insertion of the instrument into an operable engagement with the retaining assembly. Upon withdrawal of the instrument, the seal member returns to a sealing configuration (without rebonding between one or more portions of the seal member) to close the passage and provide electrical and fluid isolation to the interconnection of the device and one or more leads.
It will be appreciated by those skilled in the art that the teachings associated with the present seal member (i.e., including a lubricated passage) may be applied to all seals including one or more passages that are breached by, for example, an instrument and which must be sealed upon the removal of the instrument. For instance, the seal member may be used in systems for pacing, cardioversion/ defibrillation, neuromuscular stimulation, bone growth stimulation and the like. Additionally, although the present seal member has been described with reference to particular materials, sizes, and shapes; any suitable size, shape, or materials may be used without departing from the scope of the invention discussed herein.
While
It is to be understood that the above description is intended to be illustrative, and not restrictive. For example, the above-described embodiments (and/or aspects thereof) may be used in combination with each other. Many other embodiments will be apparent to those of skill in the art upon reviewing the above description. The scope of the present assemblies and methods should, therefore, be determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled. In the appended claims, the terms “including” and “in which” are used as the plain-English equivalents of the respective terms “comprising” and “wherein.” Also, in the following claims, the terms “including” and “comprising” are open-ended, that is, a system, device, article, or process that includes elements in addition to those listed after such a term in a claim are still deemed to fall within the scope of that claim. Moreover, in the following claims, the terms “first,” “second,” and “third,” etc. are used merely as labels, and are not intended to impose numerical requirements on their objects.
The Abstract of the Disclosure is provided to comply with 37 C.F.R. §1.72(b), requiring an abstract that will allow the reader to quickly ascertain the nature of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. In addition, in the foregoing Detailed Description, various features may be grouped together to streamline the disclosure. This method of disclosure is not to be interpreted as reflecting an intention that the claimed embodiments require more features than are expressly recited in each claim. Rather, as the following claims reflect, inventive subject matter may lie in less than all features of a single disclosed embodiment. Thus the following claims are hereby incorporated into the Detailed Description, with each claim standing on its own as a separate embodiment.